» Articles » PMID: 32194851

CNTNAP4 Deficiency in Dopaminergic Neurons Initiates Parkinsonian Phenotypes

Overview
Journal Theranostics
Date 2020 Mar 21
PMID 32194851
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

: Contactin-associated protein-like 4 (CNTNAP4) belongs to the neurexin superfamily and has critical functions in neurological development and synaptic function. Loss of CNTNAP4 in interneurons has been linked to autism, schizophrenia, and epilepsy. CNTNAP4 is also highly enriched in dopaminergic (DA) neurons in the substantia nigra (SN), however, few studies have investigated the role of CNTNAP4 in DA neurons, and whether CNTNAP4 deficiency in DA neurons contributes to Parkinson's disease (PD) remains unclear. : Effects of CNTNAP4 knockdown or overexpression on the DA MN9D cell line were assessed via Western blotting, immunocytochemistry, and RNA sequencing. An animal model, including CNTNAP4 knockout mice and stereotaxic injections of adeno-associated viral short-hairpin RNA with the tyrosine-hydroxylase promotor to silence CNTNAP4 in the SN, as well as the resulting physiological/behavioral effects, were evaluated via behavioral tests, Western blotting, immunohistochemistry, and transmission electron microscopy. Enzyme-linked immunosorbent assays (ELISAs) were performed to examine the cerebrospinal fluid (CSF) and plasma CNTNAP4 concentrations in PD patients. : We demonstrated that CNTNAP4 knockdown induced mitophagy and increased α-synuclein expression in MN9D cells. CNTNAP4 knockdown in the SN induced PD-like increases in SN-specific α-synuclein expression, DA neuronal degeneration, and motor dysfunction in mice. In addition, CNTNAP4 knockdown in SN-DA neurons increased autophagosomes and reduced synaptic vesicles in the SN. Furthermore, CNTNAP4 knockout mice showed movement deficits, nigral DA degeneration, and increased autophagy, which were consistent with the SN-specific knockdown model. We also found that CSF and plasma CNTNAP4 expression was increased in PD patients; in particular, plasma CNTNAP4 was increased in male PD patients compared with controls or female PD patients. : Our findings suggest that CNTNAP4 deficiency may initiate phenotypes relevant to PD, of which we elucidated some of the underlying mechanisms.

Citing Articles

Histone H3 lysine 9 tri-methylation is associated with pterygium.

Choi D, Na A, Jeoung S, Choi Y, Park N, Park H BMC Ophthalmol. 2025; 25(1):106.

PMID: 40033254 PMC: 11874390. DOI: 10.1186/s12886-025-03939-7.


Impact of LITAF on Mitophagy and Neuronal Damage in Epilepsy via MCL-1 Ubiquitination.

Min F, Dong Z, Zhong S, Li Z, Wu H, Zhang S CNS Neurosci Ther. 2025; 31(1):e70191.

PMID: 39764629 PMC: 11705406. DOI: 10.1111/cns.70191.


nlr-1/CNTNAP regulates dopamine circuit structure and foraging behaviors in C. elegans.

Bastien B, Haury W, Smisko W, Hart M Commun Biol. 2024; 7(1):1248.

PMID: 39358459 PMC: 11447218. DOI: 10.1038/s42003-024-06936-6.


Extended genome-wide association study employing the African genome resources panel identifies novel susceptibility loci for Alzheimer's disease in individuals of African ancestry.

Ray N, Kunkle B, Hamilton-Nelson K, Kurup J, Rajabli F, Qiao M Alzheimers Dement. 2024; 20(8):5247-5261.

PMID: 38958117 PMC: 11350055. DOI: 10.1002/alz.13880.


Genetic modifiers of synucleinopathies-lessons from experimental models.

Lee R, Koh T Oxf Open Neurosci. 2024; 2:kvad001.

PMID: 38596238 PMC: 10913850. DOI: 10.1093/oons/kvad001.


References
1.
Suzuki K, Suzuki S, Ishii Y, Fujita H, Matsubara T, Okamura M . Serum insulin-like growth factor-1 levels in neurodegenerative diseases. Acta Neurol Scand. 2019; 139(6):563-567. DOI: 10.1111/ane.13091. View

2.
Wang X, Becker K, Levine N, Zhang M, Lieberman A, Moore D . Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathol Commun. 2019; 7(1):41. PMC: 6419482. DOI: 10.1186/s40478-019-0696-4. View

3.
Shangguan Y, Xu X, Ganbat B, Li Y, Wang W, Yang Y . CNTNAP4 Impacts Epilepsy Through GABAA Receptors Regulation: Evidence From Temporal Lobe Epilepsy Patients and Mouse Models. Cereb Cortex. 2017; 28(10):3491-3504. DOI: 10.1093/cercor/bhx215. View

4.
Ryan B, Hoek S, Fon E, Wade-Martins R . Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease. Trends Biochem Sci. 2015; 40(4):200-10. DOI: 10.1016/j.tibs.2015.02.003. View

5.
Fearnley J, Lees A . Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 1991; 114 ( Pt 5):2283-301. DOI: 10.1093/brain/114.5.2283. View